{
  "doc_id": "10_",
  "doc_filename": "10_.pdf",
  "trial_ids": [],
  "study_design": null,
  "eligibility_inclusion": [
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "over 18 years of age",
      "section": "eligibility",
      "page": 2,
      "structured_data": {
        "type": "inclusion",
        "category": "age",
        "derived": {
          "operator": ">",
          "value": 18,
          "unit": "years"
        }
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 2,
          "quote": "over 18 years of age",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "diagnosed with either GPA, MPA or EGPA",
      "section": "eligibility",
      "page": 2,
      "structured_data": {
        "type": "inclusion",
        "category": "diagnosis",
        "derived": null
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 2,
          "quote": "who had been diagnosed with either GPA, MPA or EGPA",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "positive for ANCA",
      "section": "eligibility",
      "page": 2,
      "structured_data": {
        "type": "inclusion",
        "category": "biomarker",
        "derived": {
          "operator": "boolean"
        }
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 2,
          "quote": "all patients had been or were positive for ANCA",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "participated in the VASKA study at Karolinska University Hospital, Sweden, between 2008 and 2022",
      "section": "eligibility",
      "page": 2,
      "structured_data": {
        "type": "inclusion",
        "category": "other",
        "derived": null
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 2,
          "quote": "who participated in the VASKA study at Karolinska University Hospital, Sweden, between 2008 and 2022",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "answered at least one of the patient-reported questionnaires",
      "section": "eligibility",
      "page": 2,
      "structured_data": {
        "type": "inclusion",
        "category": "other",
        "derived": {
          "operator": ">=",
          "value": 1
        }
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 2,
          "quote": "To be included in the present study, participants had to have answered at least one of the patient-reported questionnaires",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "Informed consent was obtained from all participants",
      "section": "eligibility",
      "page": 2,
      "structured_data": {
        "type": "inclusion",
        "category": "consent",
        "derived": {
          "operator": "boolean"
        }
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 2,
          "quote": "Informed consent was obtained from all participants",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    }
  ],
  "eligibility_exclusion": [],
  "epidemiology": [],
  "patient_journey": [],
  "endpoints": [
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Health-related quality of life",
      "section": "endpoints",
      "page": 1,
      "structured_data": {
        "type": "primary",
        "name": "Health-related quality of life",
        "measure": "EuroQoL five-dimension three-level questionnaire (EQ-5D-3L) and visual analogue scale (EQ-VAS)",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Median and IQR distributions, Mann-Whitney U test or Kruskal-Wallis H test for group comparisons"
      },
      "confidence": 0.44,
      "evidence": [
        {
          "page": 1,
          "quote": "To explore health-related quality of life (HROoL), anxiety, depression and fatigue among persons with ANCA-associated vasculitis (AAV)",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Anxiety",
      "section": "endpoints",
      "page": 1,
      "structured_data": {
        "type": "secondary",
        "name": "Anxiety",
        "measure": "Hospital Anxiety and Depression Score - Anxiety (HADS-A)",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Median and IQR distributions, Mann-Whitney U test or Kruskal-Wallis H test for group comparisons"
      },
      "confidence": 0.44,
      "evidence": [
        {
          "page": 1,
          "quote": "To explore health-related quality of life (HROoL), anxiety, depression and fatigue among persons with ANCA-associated vasculitis (AAV)",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Depression",
      "section": "endpoints",
      "page": 1,
      "structured_data": {
        "type": "secondary",
        "name": "Depression",
        "measure": "Hospital Anxiety and Depression Score - Depression (HADS-D)",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Median and IQR distributions, Mann-Whitney U test or Kruskal-Wallis H test for group comparisons"
      },
      "confidence": 0.44,
      "evidence": [
        {
          "page": 1,
          "quote": "To explore health-related quality of life (HROoL), anxiety, depression and fatigue among persons with ANCA-associated vasculitis (AAV)",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Fatigue",
      "section": "endpoints",
      "page": 1,
      "structured_data": {
        "type": "secondary",
        "name": "Fatigue",
        "measure": "Multidimensional Assessment of Fatigue questionnaire (MAF)",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Median and IQR distributions, Mann-Whitney U test or Kruskal-Wallis H test for group comparisons"
      },
      "confidence": 0.44,
      "evidence": [
        {
          "page": 1,
          "quote": "To explore health-related quality of life (HROoL), anxiety, depression and fatigue among persons with ANCA-associated vasculitis (AAV)",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Bivariate correlations with disease activity",
      "section": "endpoints",
      "page": 2,
      "structured_data": {
        "type": "exploratory",
        "name": "Bivariate correlations with disease activity",
        "measure": "Spearman's rank-order correlation between disease activity and EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Spearman's rank-order correlation"
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 2,
          "quote": "Bivariate correlations between disease duration and EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D as well as disease activity and EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D were performed using Spearman's rank-order correlation",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Bivariate correlations with disease duration",
      "section": "endpoints",
      "page": 2,
      "structured_data": {
        "type": "exploratory",
        "name": "Bivariate correlations with disease duration",
        "measure": "Spearman's rank-order correlation between disease duration and EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Spearman's rank-order correlation"
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 2,
          "quote": "Bivariate correlations between disease duration and EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D as well as disease activity and EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D were performed using Spearman's rank-order correlation",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Cluster analysis",
      "section": "endpoints",
      "page": 2,
      "structured_data": {
        "type": "exploratory",
        "name": "Cluster analysis",
        "measure": "Hierarchical cluster analysis based on EQ-5D index, EQ-VAS, HADS-A and HADS-D",
        "timepoint": "Cross-sectional assessment",
        "analysis_method": "Hierarchical agglomerative clustering procedure using average linkage"
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 2,
          "quote": "A hierarchical cluster analysis was performed to create clusters of individuals with AAV, based on EQ-5D index, EQ-VAS, HADS-A and HADS-D",
          "source_node_id": null,
          "source_doc_id": "10_"
        }
      ]
    }
  ],
  "sites": [
    {
      "field_type": "STUDY_SITE",
      "text": "Sweden",
      "section": "sites",
      "page": null,
      "structured_data": {
        "country": "Sweden",
        "site_count": 1
      },
      "confidence": 0.85,
      "evidence": []
    }
  ],
  "operational_burden": {
    "invasive_procedures": [],
    "visit_schedule": {
      "total_visits": null,
      "visit_days": [],
      "frequency": null,
      "duration_weeks": null,
      "scheduled_visits": [],
      "pre_randomization_days": [],
      "on_treatment_days": [],
      "follow_up_days": [],
      "evidence": []
    },
    "central_lab_required": false,
    "central_lab": null,
    "special_sample_handling": [],
    "vaccination_requirements": [],
    "background_therapy": [],
    "concomitant_meds_allowed": [],
    "run_in_duration_days": null,
    "run_in_requirements": [],
    "burden_score": null,
    "site_complexity_score": null,
    "hard_gates": []
  },
  "screening_flow": {
    "planned_sample_size": null,
    "actual_enrollment": null,
    "screened": null,
    "screen_failures": null,
    "randomized": null,
    "treated": null,
    "completed": 296,
    "discontinued": null,
    "screening_yield": null,
    "screen_failure_rate": null,
    "dropout_rate": null,
    "screen_failure_rate_reported": null,
    "screen_failure_rate_computed": null,
    "screen_fail_reasons": [],
    "reasons_can_overlap": false,
    "run_in_failures": null,
    "run_in_failure_reasons": [],
    "evidence": [
      {
        "page": 3,
        "section_header": null,
        "quote": "A total of 296 patients had answered at least one of the patient-reported outcomes and hence were included in the study",
        "char_start": null,
        "char_end": null,
        "bbox": null,
        "source_node_id": null,
        "source_doc_id": "10_"
      },
      {
        "page": 3,
        "section_header": null,
        "quote": "EQ-5D-3L was completed by 282 patients, EQ-VAS by 271, HADS by 283 and MAF by 256 patients",
        "char_start": null,
        "char_end": null,
        "bbox": null,
        "source_node_id": null,
        "source_doc_id": "10_"
      },
      {
        "page": 5,
        "section_header": null,
        "quote": "The cluster analysis included 245 individuals",
        "char_start": null,
        "char_end": null,
        "bbox": null,
        "source_node_id": null,
        "source_doc_id": "10_"
      }
    ]
  },
  "extraction_timestamp": "2026-02-04T15:41:05.672816"
}